CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

NCT01746173 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Slow accrual and futility

Conditions

T-cell Non-Hodgkin Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Etoposide
DRUG: Prednisone
DRUG: Filgrastim
DRUG: Plerixafor
PROCEDURE: Stem Cell Collection
DRUG: Palifermin
DRUG: Gemcitabine
DRUG: Busulfan
DRUG: Melphalan
PROCEDURE: Stem Cell Transplant

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]